BRIEF-Alnylam Pharmaceuticals Q4 Adjusted Net Income USD 8.048 Million Vs. IBES Estimate USD -76.1 Million

Reuters
13 Feb
BRIEF-Alnylam Pharmaceuticals Q4 Adjusted Net Income USD 8.048 Million Vs. IBES Estimate USD -76.1 Million

Feb 13 (Reuters) - Alnylam Pharmaceuticals Q4 operating income USD -105.159 million.

  • Q4 adjusted operating income USD -13.514 million vs. IBES estimate USD -63.4 million
  • Q4 net income USD -83.763 million

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10